Gentherapeutische ansatze in der arthrosebehandlung

Translated title of the contribution: Therapy of arthritis by gene transfer

H. D. Möller, Christopher H Evans

Research output: Contribution to journalArticle

Abstract

Current concepts in treating arthritis by gene transfer are described, including different vector systems and strategies of gene transfer into target cells. Promising antiarthritic gene products are a variety of growth factors which facilitate increased matrix synthesis and mitogenesis in articular chondrocytes. Furthermore, rheumatoid joint destruction can be treated genetically by the transfer of certain antiinflammatory cytokine genes, which provide locally high concentrations of the antiinflammatory gene product. First clinical trails using the IRAP gene (interleukin I receptor antagonist protein) to eliminate the inflammatory reaction caused by interleukin I in rheumatoid joints are on its way. In order to investigate potential improvement in cartilage regeneration retroviral TGF-β gene transfer in rabbit articular chondrocytes has been carried out. The TGF-β group showed an in vitro increase in collagen type II neosynthesis by 304%, compared to normal chondrocytes.

Original languageGerman
Pages (from-to)76-81
Number of pages6
JournalOrthopade
Volume28
Issue number1
DOIs
StatePublished - Jan 1999
Externally publishedYes

Fingerprint

Genetic Therapy
Arthritis
Genes
Chondrocytes
Joints
Interleukin-1
Anti-Inflammatory Agents
Interleukin Receptors
Collagen Type II
Cartilage
Regeneration
Intercellular Signaling Peptides and Proteins
Cytokines
Rabbits
Proteins

Keywords

  • Articular cartilage
  • Gene transfer
  • Growth factors
  • Matrix synthesis

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

Gentherapeutische ansatze in der arthrosebehandlung. / Möller, H. D.; Evans, Christopher H.

In: Orthopade, Vol. 28, No. 1, 01.1999, p. 76-81.

Research output: Contribution to journalArticle

Möller, H. D. ; Evans, Christopher H. / Gentherapeutische ansatze in der arthrosebehandlung. In: Orthopade. 1999 ; Vol. 28, No. 1. pp. 76-81.
@article{18402644946d4855a80ef6b25ee5af03,
title = "Gentherapeutische ansatze in der arthrosebehandlung",
abstract = "Current concepts in treating arthritis by gene transfer are described, including different vector systems and strategies of gene transfer into target cells. Promising antiarthritic gene products are a variety of growth factors which facilitate increased matrix synthesis and mitogenesis in articular chondrocytes. Furthermore, rheumatoid joint destruction can be treated genetically by the transfer of certain antiinflammatory cytokine genes, which provide locally high concentrations of the antiinflammatory gene product. First clinical trails using the IRAP gene (interleukin I receptor antagonist protein) to eliminate the inflammatory reaction caused by interleukin I in rheumatoid joints are on its way. In order to investigate potential improvement in cartilage regeneration retroviral TGF-β gene transfer in rabbit articular chondrocytes has been carried out. The TGF-β group showed an in vitro increase in collagen type II neosynthesis by 304{\%}, compared to normal chondrocytes.",
keywords = "Articular cartilage, Gene transfer, Growth factors, Matrix synthesis",
author = "M{\"o}ller, {H. D.} and Evans, {Christopher H}",
year = "1999",
month = "1",
doi = "10.1007/s001320050324",
language = "German",
volume = "28",
pages = "76--81",
journal = "Der Orthopade",
issn = "0085-4530",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Gentherapeutische ansatze in der arthrosebehandlung

AU - Möller, H. D.

AU - Evans, Christopher H

PY - 1999/1

Y1 - 1999/1

N2 - Current concepts in treating arthritis by gene transfer are described, including different vector systems and strategies of gene transfer into target cells. Promising antiarthritic gene products are a variety of growth factors which facilitate increased matrix synthesis and mitogenesis in articular chondrocytes. Furthermore, rheumatoid joint destruction can be treated genetically by the transfer of certain antiinflammatory cytokine genes, which provide locally high concentrations of the antiinflammatory gene product. First clinical trails using the IRAP gene (interleukin I receptor antagonist protein) to eliminate the inflammatory reaction caused by interleukin I in rheumatoid joints are on its way. In order to investigate potential improvement in cartilage regeneration retroviral TGF-β gene transfer in rabbit articular chondrocytes has been carried out. The TGF-β group showed an in vitro increase in collagen type II neosynthesis by 304%, compared to normal chondrocytes.

AB - Current concepts in treating arthritis by gene transfer are described, including different vector systems and strategies of gene transfer into target cells. Promising antiarthritic gene products are a variety of growth factors which facilitate increased matrix synthesis and mitogenesis in articular chondrocytes. Furthermore, rheumatoid joint destruction can be treated genetically by the transfer of certain antiinflammatory cytokine genes, which provide locally high concentrations of the antiinflammatory gene product. First clinical trails using the IRAP gene (interleukin I receptor antagonist protein) to eliminate the inflammatory reaction caused by interleukin I in rheumatoid joints are on its way. In order to investigate potential improvement in cartilage regeneration retroviral TGF-β gene transfer in rabbit articular chondrocytes has been carried out. The TGF-β group showed an in vitro increase in collagen type II neosynthesis by 304%, compared to normal chondrocytes.

KW - Articular cartilage

KW - Gene transfer

KW - Growth factors

KW - Matrix synthesis

UR - http://www.scopus.com/inward/record.url?scp=0032602091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032602091&partnerID=8YFLogxK

U2 - 10.1007/s001320050324

DO - 10.1007/s001320050324

M3 - Article

C2 - 10081047

VL - 28

SP - 76

EP - 81

JO - Der Orthopade

JF - Der Orthopade

SN - 0085-4530

IS - 1

ER -